Hindustan Syringes and Medical Devices

Hindustan Syringes & Medical Devices (HMD) invested over USD 15 million (approx. ₹100 crore) from its own resources in May 2020 to mass produce specialty syringes for COVID-19 vaccination, followed by a second round of over ₹100 crore in 2021-22.

Hindustan Syringes and Medical Devices (HMD) aims to increase its total syringe production capacity to 3.5 billion pieces per year by March 2022, including 1.25 billion auto-disable syringes. The company has invested over $15 million since May 2020.

Hindustan Syringes and Medical Devices (HMD) will invest over ₹100 crore to expand its syringe production capacity from 2.5 billion to over 3 billion syringes per annum by the next quarter.

Hindustan Syringes & Medical Devices Ltd received a government order for 265 million AD syringes to supply till September 2021, against a 350 million tender for which they were L1.

Hindustan Syringes and Medical Devices (HMD) plans to increase its annual production capacity of auto-disable syringes from 57 crore units to 100 crore units by the second quarter of 2021 to meet anticipated COVID-19 vaccine demand.